Developmental aspects of experimental pulmonary oxygen toxicity

Free Radical Biology & Medicine
L Frank


One of the more fascinating aspects of in vivo research on pulmonary O2 toxicity is the striking difference in the response of the neonatal versus the adult animal to hyperoxia. In general, neonatal animals are much more resistant to the characteristic O2-induced lung pathology seen in adult animals in hyperoxia. Neonatal animals are also able to rapidly mount a protective lung biochemical response to high O2 exposure [increased pulmonary antioxidant enzyme (AOE) activities], an adaptive response which adult animals have lost the ability to manifest in greater than 95% O2. This review focuses on the disparate AOE responses of the neonatal versus adult animal in hyperoxia. It also explores other possible explanations for the striking O2 tolerance of young versus adult animals, including comparative O2 free radical production rates, inflammatory cell responses, lung lipid composition, repair capabilities, etc. Discussion also centers on a less well studied toxic complication associated with hyperoxic exposure in the neonatal animal, i.e., the marked inhibitory effect of O2 exposure on normal lung growth and development of an alveolarized lung with an expanded respiratory exchange surface area. Finally, effective experimental mean...Continue Reading


Sep 1, 1979·Archives of Biochemistry and Biophysics·H M Hassan, I Fridovich
Mar 1, 1979·Reviews of Infectious Diseases·H M Hassan, I Fridovich
Feb 1, 1979·Toxicology and Applied Pharmacology·J Yam, R J Roberts
Feb 1, 1978·The Journal of Clinical Investigation·L FrankR J Roberts
Jan 1, 1978·Biology of the Neonate·J P Kehrer, A P Autor
Mar 1, 1991·Mutation Research·M Poot
Jan 1, 1990·Free Radical Biology & Medicine·B A OmarJ M McCord
Jan 1, 1991·American Journal of Respiratory Cell and Molecular Biology·S F RyanD F Liau
Feb 11, 1991·The American Review of Respiratory Disease·L R MargrafB B Dahms
Jan 1, 1991·Experimental Lung Research·F J WaltherH J Forman
May 1, 1991·American Journal of Respiratory Cell and Molecular Biology·P G DuaneD E Niewoehner
Jan 1, 1990·Free Radical Biology & Medicine·K D Munkres
Oct 1, 1990·Acta paediatrica Scandinavica·O D Saugstad
Dec 1, 1990·Pediatric Research·T N HansenM Giesler
Jan 1, 1990·Pediatric Pulmonology·C LortieI Y Adamson
Jan 1, 1989·Free Radical Biology & Medicine·D Jamieson
Aug 1, 1989·The American Review of Respiratory Disease·J E Heffner, J E Repine
Oct 1, 1989·The American Review of Respiratory Disease·M C BruceJ F Tomashefski
May 1, 1989·Experimental Lung Research·N W BoyceS R Holdsworth
Apr 1, 1989·Prostaglandins·R B HoltzmanJ R Hageman
Mar 1, 1988·The American Review of Respiratory Disease·H MansourJ J Pocidalo
Apr 1, 1988·Mayo Clinic Proceedings·P A Southorn, G Powis
Jan 1, 1988·Free Radical Biology & Medicine·H M Hassan
Jan 1, 1988·Free Radical Biology & Medicine·J Kedziora, G Bartosz
Jan 1, 1988·Experimental Lung Research·J R HoidalT P Kennedy

❮ Previous
Next ❯


Jan 1, 1994·Medical Oncology·P M Schwartsburd, V Z Lankin
Mar 1, 1993·Journal of the Neurological Sciences·E S de LustigR O Dominguez
Nov 1, 1993·Toxicology in Vitro : an International Journal Published in Association with BIBRA·C V BarberA G Fantel
May 1, 1993·Free Radical Biology & Medicine·J D StenzelT N Hansen
Jun 1, 1993·Free Radical Biology & Medicine·D TorbatiG A Peyman
Oct 1, 1995·Free Radical Biology & Medicine·P A DenneryD K Stevenson
Feb 5, 2004·Journal of the Neurological Sciences·Jorge A SerraUNKNOWN Collaborative Group for the Study of the Oxidative Stress, Argentina
Oct 6, 2000·Clinica Chimica Acta; International Journal of Clinical Chemistry·J A SerraE M Guareschi
Jan 1, 1997·Free Radical Biology & Medicine·T P RyanT W Petry
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·R M LebovitzM M Matzuk
Dec 11, 2008·Toxicological Sciences : an Official Journal of the Society of Toxicology·Elizabeth M VanczaTerry Gordon
Jan 1, 1996·Critical Care Medicine·M ContrerasJ J Zimmerman
Dec 17, 2009·American Journal of Physiology. Lung Cellular and Molecular Physiology·Vivek BalasubramaniamSteven H Abman
Aug 24, 2010·American Journal of Physiology. Lung Cellular and Molecular Physiology·Virender K RehanJohn S Torday
Jan 20, 2009·American Journal of Physiology. Lung Cellular and Molecular Physiology·Sharon McGrath-MorrowShyam Biswal
Jan 1, 1995·Mediators of Inflammation·M R PierceM J Miller
Jun 11, 2003·American Journal of Respiratory and Critical Care Medicine·Vuokko L Kinnula, James D Crapo
Feb 26, 1998·American Journal of Respiratory Cell and Molecular Biology·S A McGrath
Dec 9, 1998·American Journal of Respiratory Cell and Molecular Biology·T M AsikainenV L Kinnula
Apr 1, 1999·American Journal of Respiratory Cell and Molecular Biology·S FoggG A Visner
Jun 6, 2000·American Journal of Respiratory Cell and Molecular Biology·D J O'DonovanS E Welty
Apr 18, 2001·American Journal of Respiratory Cell and Molecular Biology·A M IlizarovJ M Davis
Aug 18, 2001·American Journal of Respiratory Cell and Molecular Biology·S A McGrath-Morrow, J Stahl
Aug 2, 2002·American Journal of Respiratory Cell and Molecular Biology·Han-Suk KimAron B Fisher
May 23, 2003·American Journal of Respiratory Cell and Molecular Biology·Sandra PerkowskiSteven M Albelda
Dec 1, 1996·Pediatric Research·P A DenneryV Shokoohi
Dec 1, 2001·Pediatric Research·R P JankovA K Tanswell
Aug 24, 2002·Pediatric Research·Floor A JenniskensCharles V Smith
May 23, 2007·Pediatric Research·Cynthia MasalungaElsie S Mainali
Dec 4, 2013·Antioxidants & Redox Signaling·Sara K Berkelhamer, Kathryn N Farrow
Jan 3, 2014·Antioxidants & Redox Signaling·Phyllis A Dennery

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.